Impact of Co-morbidities and Patient Characteristics on International Normalized Ratio Control Over Time in Patients With Nonvalvular Atrial Fibrillation
| Autor: | Peter Wildgoose, Jeffrey Schein, Larry E. Fields, Julie Vanderpoel, Winnie W. Nelson, Jiyoon C. Choi, Chandrasekharra V. Damaraju |
|---|---|
| Rok vydání: | 2013 |
| Předmět: |
Adult
Male medicine.medical_specialty Time Factors Comorbidity Decision Support Techniques Diabetes Complications Risk Factors Internal medicine Diabetes mellitus Atrial Fibrillation medicine Humans International Normalized Ratio Longitudinal Studies Stroke Aged Heart Failure business.industry Warfarin Anticoagulants Atrial fibrillation Odds ratio Middle Aged medicine.disease Confidence interval Logistic Models Heart failure Hypertension Cardiology Female business Cardiology and Cardiovascular Medicine Software medicine.drug |
| Zdroj: | The American Journal of Cardiology. 112(4):509-512 |
| ISSN: | 0002-9149 |
| DOI: | 10.1016/j.amjcard.2013.04.013 |
| Popis: | This study determined the association between co-morbidities, including heart failure (HF) and time in therapeutic range (TTR), in patients with nonvalvular atrial fibrillation. Longitudinal patient-level anticoagulation management records collected from 2006 to 2010 were analyzed. Adult patients with nonvalvular atrial fibrillation who used warfarin for a 12-month period with no gap of >60 days between visits were identified. TTR |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect